Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
29,568,032
-
Shares change
-
+2,705,428
-
Total reported value, excl. options
-
$251,891,278
-
Value change
-
+$21,737,929
-
Put/Call ratio
-
899%
-
Number of buys
-
39
-
Number of sells
-
-32
-
Price
-
$8.52
Significant Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2016
93 filings reported holding TGTX - TG THERAPEUTICS, INC. - COMMON STOCK as of Q1 2016.
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,568,032 shares
of 158,835,667 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include FMR LLC (6,025,425 shares), RA CAPITAL MANAGEMENT, LLC (4,531,714 shares), BRIDGER MANAGEMENT, LLC (3,345,469 shares), UBS ASSET MANAGEMENT AMERICAS INC (2,021,310 shares), BAKER BROS. ADVISORS LP (2,003,991 shares), Sectoral Asset Management Inc (1,521,667 shares), VANGUARD GROUP INC (1,331,433 shares), STATE STREET CORP (1,181,038 shares), BlackRock Fund Advisors (981,545 shares), and BlackRock Institutional Trust Company, N.A. (926,707 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.